Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
Go back to Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data| (NASDAQ: PLSE) | Delayed: 28.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.33 | 52 Week High | $6.77 | |||
| Open | $28.33 | 52 Week Low | $4.03 | |||
| Day High | $28.33 | P/E | N/A | |||
| Day Low | $28.33 | EPS | $0.00 | |||
| Volume | 1 | |||||
